Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Doxycycline Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/14/2021 6 0
Bromelain Potential treatment - pre-clinical evidence Natural product Antiviral Mar/06/2021 2 0
Ethaselen Potential treatment - theoretical effect Experimental Antiviral Feb/23/2021 1 0
Nilotinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021 4 0
Deguelin Potential treatment - pre-clinical evidence Natural product Antiviral Feb/09/2021 1 0
Sorafenib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021 2 0
Excel (.xslx) CSV (.csv)